Execus (EXEC) H1 2024 earnings summary

Executive summary

• H1 revenue rose 68.3% YoY on the reported basis, largely reflecting the first-time inclusion of Adasta and Differens; on a comparable-perimeter basis, revenue fell 16.6%.

• EBITDA fell to €87k and the period ended with a €221k consolidated net loss; indirect-channel weakness and higher operating costs pressured profitability.

Financial highlights

• Revenue was €2.044m (+68.3% YoY) and production value was €2.157m (+75.6%); comparable-perimeter production value declined 13.3%.

• EBITDA was €87k versus €488k in H1 2023; margin on production value was 4.0% versus 39.8%.

• EBIT was -€192k versus €364k; net loss was €221k versus net income of €257k.

• Comparable-perimeter EBITDA was €87k versus €753k, with margin falling to 4.0% from 30.3%.

Outlook and guidance

• Priorities include expanding direct sales, launching AI-enabled products, improving operating efficiency and pursuing acquisitions; no quantified financial guidance was presented.

• Four senior sales hires were planned between June 2024 and January 2025, with significant compensation tied to a sales plan through December 2026; three joined by September and a fourth was expected mid-October.

• Higher costs and investment are expected to weigh on 2024 margins, while benefits from growth initiatives are expected in the short to medium term; indirect-channel activity is being phased out.